A phase 1/2, open-label, randomized, dose-finding and dose expansion study of gedatolisib in combination with darolutamide in metastatic castration-resistant prostate cancer (mCRPC). This is an ASCO ...
Every router sold in the past decade keeps a live list of every phone, laptop, smart speaker, and security camera attached to it. Pulling up that list takes about 30 seconds, and the results can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results